218 related articles for article (PubMed ID: 33685999)
1. De novo
Ragamin A; Gomes CC; Bindels-de Heus K; Sandoval R; Bassenden AV; Dib L; Kok F; Alves J; Mathijssen I; Medici-Van den Herik E; Eveleigh R; Gayden T; Pullens B; Berghuis A; van Slegtenhorst M; Wilke M; Jabado N; Mancini GMS; Gomez RS
J Med Genet; 2022 Mar; 59(3):305-312. PubMed ID: 33685999
[TBL] [Abstract][Full Text] [Related]
2. TRPV4-pathy, a novel channelopathy affecting diverse systems.
Dai J; Cho TJ; Unger S; Lausch E; Nishimura G; Kim OH; Superti-Furga A; Ikegawa S
J Hum Genet; 2010 Jul; 55(7):400-2. PubMed ID: 20505684
[TBL] [Abstract][Full Text] [Related]
3. TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw.
Gomes CC; Gayden T; Bajic A; Harraz OF; Pratt J; Nikbakht H; Bareke E; Diniz MG; Castro WH; St-Onge P; Sinnett D; Han H; Rivera B; Mikael LG; De Jay N; Kleinman CL; Valera ET; Bassenden AV; Berghuis AM; Majewski J; Nelson MT; Gomez RS; Jabado N
Nat Commun; 2018 Nov; 9(1):4572. PubMed ID: 30385747
[TBL] [Abstract][Full Text] [Related]
4. Association of novel mutation in TRPV4 with familial nonsyndromic craniosynostosis with complete penetrance and variable expressivity.
Gayden T; Crevier-Sorbo G; Jawhar W; Saint-Martin C; Eveleigh R; Gilardino MS; Anastasio N; Trakadis Y; Bassenden AV; Berghuis AM; Jabado N; Dudley RWR
J Neurosurg Pediatr; 2023 Jun; 31(6):584-592. PubMed ID: 36905673
[TBL] [Abstract][Full Text] [Related]
5. TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function.
Taga A; Peyton MA; Goretzki B; Gallagher TQ; Ritter A; Harper A; Crawford TO; Hellmich UA; Sumner CJ; McCray BA
Ann Clin Transl Neurol; 2022 Mar; 9(3):375-391. PubMed ID: 35170874
[TBL] [Abstract][Full Text] [Related]
6. Making sense of giant cell lesions of the jaws (GCLJ): lessons learned from next-generation sequencing.
Gomes CC; Diniz MG; Bastos VC; Bernardes VF; Gomez RS
J Pathol; 2020 Feb; 250(2):126-133. PubMed ID: 31705763
[TBL] [Abstract][Full Text] [Related]
7. The puzzle of TRPV4 channelopathies.
Nilius B; Voets T
EMBO Rep; 2013 Feb; 14(2):152-63. PubMed ID: 23306656
[TBL] [Abstract][Full Text] [Related]
8. Protein informatics combined with multiple data sources enriches the clinical characterization of novel TRPV4 variant causing an intermediate skeletal dysplasia.
Hines SL; Richter JE; Mohammad AN; Mahim J; Atwal PS; Caulfield TR
Mol Genet Genomic Med; 2019 Mar; 7(3):e566. PubMed ID: 30693671
[TBL] [Abstract][Full Text] [Related]
9. A new TRPV4 mutation in a case of multiple central giant cell granulomas of the jaws.
Guimarães LM; Martins-Chaves RR; Chabot PQ; Schreuder WH; de Castro WH; Gomez RS; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Mar; 135(3):e68-e73. PubMed ID: 36529675
[TBL] [Abstract][Full Text] [Related]
10. A channelopathy mechanism revealed by direct calmodulin activation of TrpV4.
Loukin SH; Teng J; Kung C
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9400-5. PubMed ID: 26170305
[TBL] [Abstract][Full Text] [Related]
11. Human skeletal dysplasia causing L596P-mutant alters the conserved amino acid pattern at the lipid-water-Interface of TRPV4.
Das R; Mohanta S; Dubey NK; Das NK; Goswami C
Biochim Biophys Acta Biomembr; 2023 Feb; 1865(2):184085. PubMed ID: 36403799
[TBL] [Abstract][Full Text] [Related]
12. TRPV4-mediated channelopathies.
Verma P; Kumar A; Goswami C
Channels (Austin); 2010; 4(4):319-28. PubMed ID: 20676052
[TBL] [Abstract][Full Text] [Related]
13. Follistatin in chondrocytes: the link between TRPV4 channelopathies and skeletal malformations.
Leddy HA; McNulty AL; Lee SH; Rothfusz NE; Gloss B; Kirby ML; Hutson MR; Cohn DH; Guilak F; Liedtke W
FASEB J; 2014 Jun; 28(6):2525-37. PubMed ID: 24577120
[TBL] [Abstract][Full Text] [Related]
14. TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients.
Cho TJ; Matsumoto K; Fano V; Dai J; Kim OH; Chae JH; Yoo WJ; Tanaka Y; Matsui Y; Takigami I; Monges S; Zabel B; Shimizu K; Nishimura G; Lausch E; Ikegawa S
Am J Med Genet A; 2012 Apr; 158A(4):795-802. PubMed ID: 22419508
[TBL] [Abstract][Full Text] [Related]
15. Somatic mosaicism for a lethal TRPV4 mutation results in non-lethal metatropic dysplasia.
Weinstein MM; Kang T; Lachman RS; Bamshad M; Nickerson DA; Krakow D; Cohn DH
Am J Med Genet A; 2016 Dec; 170(12):3298-3302. PubMed ID: 27530454
[TBL] [Abstract][Full Text] [Related]
16. Channelopathies converge on TRPV4.
Nilius B; Owsianik G
Nat Genet; 2010 Feb; 42(2):98-100. PubMed ID: 20104247
[TBL] [Abstract][Full Text] [Related]
17. Compound heterozygous TRPV4 mutations in two siblings with a complex phenotype including severe intellectual disability and neuropathy.
Thibodeau ML; Peters CH; Townsend KN; Shen Y; Hendson G; Adam S; Selby K; Macleod PM; Gershome C; Ruben P; Jones SJM; ; Friedman JM; Gibson WT; Horvath GA
Am J Med Genet A; 2017 Nov; 173(11):3087-3092. PubMed ID: 28898540
[TBL] [Abstract][Full Text] [Related]
18. The amino-terminal domain of TRPV4 channel is involved in its trafficking to the nucleus.
Méndez-Gómez S; Espadas-Álvarez H; Ramírez-Rodríguez I; Domínguez-Malfavón L; García-Villegas R
Biochem Biophys Res Commun; 2022 Feb; 592():13-17. PubMed ID: 35007845
[TBL] [Abstract][Full Text] [Related]
19. Novel TRPV4 mutation in a large Chinese family with congenital distal spinal muscular atrophy, skeletal dysplasia and scaly skin.
Liu Y; Yan X; Chen Y; He Z; Ouyang Y
J Neurol Sci; 2020 Dec; 419():117153. PubMed ID: 33075594
[TBL] [Abstract][Full Text] [Related]
20. TRPV4-associated skeletal dysplasias.
Nishimura G; Lausch E; Savarirayan R; Shiba M; Spranger J; Zabel B; Ikegawa S; Superti-Furga A; Unger S
Am J Med Genet C Semin Med Genet; 2012 Aug; 160C(3):190-204. PubMed ID: 22791502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
